Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Conditions

• NF2-related Schwannomatosis

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Auto-captioning Glasses — DEVICE
  Augmented reality glasses that overlay real time captioning on see-through lenses, allowing users to read what is being said out loud.

Study Details

The goal of this clinical trial is to investigate the usability of auto-captioning glasses for adults diagnosed with NF2-related schwannomatosis and loss of hearing. The primary objective of the study is to determine the feasibility and acceptability of auto-captioning glasses in this population. Participants will be asked to: * Use the glasses at their discretion for 12 weeks * Report their feedback at 3 and 12 week timepoints via online surveys and remote qualitative interviews

Key Dates

Start date

Feb 19, 2026

Status verified

Apr 2026

Primary completion

Dec 31, 2026

Completion

Dec 31, 2026

Study Design

Enrollment

18 participants (actual)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Arms

• Experimental: Adults with NF2-SWN and Hearing Loss
  Adults with a clinical diagnosis of NF2-SWN and self reported hearing loss will use the auto-captioning glasses for 12 weeks

Primary Outcome Measure

System Usability Scale [ Time Frame: 12 Weeks ]

Locations (1)

Find similar trials in Boston, MA